Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Avecho Biotechnology Limited
  6. Summary
    AVE   AU0000047441

AVECHO BIOTECHNOLOGY LIMITED

(AVE)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
11/24/2021 11/25/2021 11/26/2021 11/29/2021 11/30/2021 Date
0.0165 0.016 0.016 0.015 0.0155 Last
47941 300000 2340411 659555 287734 Volume
0.00% -3.03% 0.00% -6.25% +3.33% Change
Estimated financial data (e)
Sales 2019 4,24 M 3,03 M 3,03 M
Net income 2019 0,85 M 0,61 M 0,61 M
Net cash position 2019 3,11 M 2,23 M 2,23 M
P/E ratio 2019 8,00x
Yield 2019 -
Sales 2020 0,38 M 0,27 M 0,27 M
Net income 2020 -2,63 M -1,88 M -1,88 M
Net cash position 2020 1,71 M 1,22 M 1,22 M
P/E ratio 2020 -17,1x
Yield 2020 -
Capitalization 28,5 M 20,2 M 20,3 M
EV / Sales 2019 0,75x
EV / Sales 2020 116x
Nbr of Employees 15
Free-Float 69,3%
More Financials
Company
Avecho Biotechnology Limited is an Australia-based company that develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The Company's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, and Veterinary Applications. The Company's segments include Production and Personal Care and Human Health. The Production and... 
More about the company
All news about AVECHO BIOTECHNOLOGY LIMITED
10/21AVECHO BIOTECHNOLOGY : Ties Up with Academic Institution for Osteoarthritis Study
MT
10/20Avecho Biotechnology Limited Announces Collaboration with the Lambert Initiative
CI
10/04AVECHO BIOTECHNOLOGY : Begins Dosing Volunteers for Phase 1 Cannabidiol Clinical Trial
MT
10/03Avecho Biotechnology Limited Announces Dosing Commences for Phase I Human Clinical Tria..
CI
09/15AVECHO BIOTECHNOLOGY : Begins Enrolment for Phase 1 Cannabidiol Absorption Trial
MT
09/14Avecho Commences Enrolment for Phase I Human Clinical Trial Measuring CBD Absorption
CI
08/23Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, ..
CI
05/26Avecho Biotechnology to Discuss Cannabidiol Soft-Gel Product with Drug Regulator; Share..
MT
05/21AVECHO BIOTECHNOLOGY : Completes Cannabidiol Soft Gel Product Design; Shares Rally 13%
MT
05/20Avecho Biotechnology Limited Completes Pharmaceutical CBD Soft-Gel Product
CI
05/04Avecho Biotechnology Limited Announces Resignation of Mr. David Segal as Director
CI
04/12AVECHO BIOTECHNOLOGY : Secures Ethics Approval for Cannabidiol Product Test on Humans
MT
04/12Avecho Biotechnology Limited Receives Ethics Approval for Cbd Human Trial
CI
02/25Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December ..
CI
2020Avecho Biotechnology Begins Observational Study on Cannabidiol Formulation; Shares Surg..
MT
More news
News in other languages on AVECHO BIOTECHNOLOGY LIMITED
10/21Avecho Biotechnology s'associe à une institution académique pour une étude sur l'arthro..
10/04Avecho Biotechnology commence à doser les volontaires pour l'essai clinique de phase 1 ..
More news
Chart AVECHO BIOTECHNOLOGY LIMITED
Duration : Period :
Avecho Biotechnology Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVECHO BIOTECHNOLOGY LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Paul David Gavin Chief Executive & Scientific Officer
Melanie Jaye Leydin Chief Financial Officer & Secretary
Gregory Collier Executive Chairman
Roksan Libinaki Chief Operating Officer
Ross Thomas Murdoch Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
AVECHO BIOTECHNOLOGY LIMITED-46.55%20
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827